Adverse events associated with prolonged antibiotic use.

Pharmacoepidemiology and Drug Safety
Sharon B MeropolJoshua P Metlay

Abstract

The Infectious Diseases Society of America and US CDC recommend 60 days of ciprofloxacin, doxycycline, or amoxicillin for anthrax prophylaxis. It is not possible to determine severe adverse drug event (ADE) risks from the few people thus far exposed to anthrax prophylaxis. This study's objective was to estimate risks of severe ADEs associated with long-term ciprofloxacin, doxycycline, and amoxicillin exposure using three large databases: one electronic medical record (General Practice Research Database) and two claims databases (UnitedHealthcare, HMO Research Network). We include office visit, hospital admission and prescription data for 1/1/1999-6/30/2001. Exposure variable was oral antibiotic person-days (pds). Primary outcome was hospitalization during exposure with ADE diagnoses: anaphylaxis, phototoxicity, hepatotoxicity, nephrotoxicity, seizures, ventricular arrhythmia, or infectious colitis. We randomly sampled 999,773, 1047,496, and 1819,004 patients from Databases A, B, and C respectively. 33,183 amoxicillin, 15,250 ciprofloxacin and 50,171 doxycycline prescriptions continued > or =30 days. ADE hospitalizations during long-term exposure were not observed in Database A. ADEs during long-term amoxicillin were seen only i...Continue Reading

References

Jan 1, 1989·Journal of Clinical Epidemiology·O S Miettinen, J J Caro
Nov 1, 1994·British Journal of Clinical Pharmacology·B BegaudF Haramburu
Mar 4, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S SegevH Reinhart
Dec 25, 2002·Emerging Infectious Diseases·Richard PlattKenneth E Sands
Sep 18, 2003·JAMA : the Journal of the American Medical Association·Sean HennessyBrian L Strom
Oct 24, 2003·The New England Journal of Medicine·Wayne A Ray
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·A D McMahonT M MacDonald
Oct 30, 2004·Current Opinion in Pulmonary Medicine·Douglas B Schwartz
Nov 16, 2005·Pharmacoepidemiology and Drug Safety·Harry A Guess
Oct 19, 2006·JAMA : the Journal of the American Medical Association·Daniel S BudnitzJoseph L Annest

❮ Previous
Next ❯

Citations

Nov 3, 2011·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Joseph R EganSteve Leach
Dec 18, 2013·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Jessica Caum, Steven Alles
Sep 13, 2012·Journal of Public Health·Joanna MurrayUNKNOWN Medicines for Neonates Investigator Group
Dec 23, 2011·Journal of Gastroenterology and Hepatology·Soichiro Miura, Ryota Hokari
Mar 20, 2013·Annals of Family Medicine·Sharon B MeropolJoshua P Metlay
Jun 5, 2014·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Malaya FletcherSteven J Alles
May 15, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Aaron J KatzPaul E Stang
Oct 1, 2011·Expert Opinion on Drug Safety·Alessandra PugiFrancesco Lapi
Jun 12, 2013·Research in Social & Administrative Pharmacy : RSAP·Richard A HansenDavid Mark Carpenter
Aug 12, 2010·FEMS Immunology and Medical Microbiology·Sławomir LetkiewiczAndrzej Górski
Nov 11, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P PuhtoH Syrjala
Nov 30, 2016·Health Security·Leisha D NolenHenry T Walke
Feb 26, 2019·Antimicrobial Agents and Chemotherapy·Giannoula S TansarliEleftherios Mylonakis
Aug 27, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Shu-Shang LuoShiuan-Pey Lin
Dec 13, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Hong LiAngela Wei Hong Yang
Dec 21, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leila S HojatTimothy C Jenkins
Feb 23, 2019·The Cochrane Database of Systematic Reviews·Shuxiong ZengChuanliang Xu
Apr 18, 2019·Pharmacoepidemiology and Drug Safety·Helen StrongmanJanet Valentine
Dec 17, 2020·The Journal of Surgical Research·Khushboo PatelBethany R Shoulders
Jan 28, 2010·Journal of Medicinal Chemistry·Dimitrios G Bouzianas
May 25, 2021·Gastroenterology Clinics of North America·Daniel Bushyhead, Eamonn M Quigley
Jul 6, 2021·Journal of Alzheimer's Disease : JAD·David R ElmalehEran Segal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Emerging Infectious Diseases
Colin W ShepardCDC Adverse Events Working Group
Emerging Infectious Diseases
Mariaelena D JefferdsCenters for Disease Control and Prevention Anthrax Adherence Team
Diagnostic Microbiology and Infectious Disease
Jennifer M StreitRonald N Jones
© 2021 Meta ULC. All rights reserved